Cost of new drugs could rise under CETA, but it's hard to predict by how much

When the Canada-EU trade deal was under negotiation, studies forecast billion-dollar price increases for Canada's health care system when brand-name drug patents are extended. Now the government won't project what the actual cost might be. Why?

from CBC | Health News http://ift.tt/2gJercb